Text Size

Glycaemic Response to a Liquid Meal Tolerance Test

This study has been completed.
Sponsor:
Collaborator:
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc.
ClinicalTrials.gov Identifier:
NCT01682174
First received: September 6, 2012
Last updated: May 7, 2013
Last verified: May 2013
History of Changes
  Purpose

The purpose of this study is to assess whether added food ingredient(s) affect glycaemic responses to a liquid meal tolerance test (LMTT).


Condition Intervention
Glycaemic Index
Glycaemic Response
 Other: Control Drink
Other: Experimental Drink

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Effects of Dehydrated Vegetable Powder on Glycaemic Responses to a Liquid Meal Tolerance Test (LMTT)

Further study details as provided by Mondelēz International, Inc.:

Primary Outcome Measures:
  • Glycaemic response (incremental area under the curve) of experimental test food using capillary blood [ Time Frame: 120 minutes ] [ Designated as safety issue: No ]

Enrollment: 13
Study Start Date: September 2012
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control Test Drink
control drink
 Other: Control Drink Other: Experimental Drink
Experimental: Experimental Test Drink
Experimental Drink
 Other: Control Drink Other: Experimental Drink

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Male or female (not less than 40% Male)
  2. Aged 18 - 55 years
  3. Non Smokers
  4. Have a body mass index between 18.5 to 29.99 kg/m2
  5. Healthy, non-diabetic, no gastric bypass surgery
  6. Not allergic to dairy, or soy
  7. Have a fasting plasma glucose (finger-stick) <100 mg/dl (<5.5 mmol/L)
  8. Willing and able to provide written informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01682174

Locations
United Kingdom
Reading Scientific Services Limited (RSSL)
Reading, Berkshire, United Kingdom
Sponsors and Collaborators
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Investigators
Principal Investigator: Rungano Munyuki RSSL
  More Information

No publications provided

Responsible Party: Mondelēz International, Inc.
ClinicalTrials.gov Identifier: NCT01682174     History of Changes
Other Study ID Numbers: P12-05775
Study First Received: September 6, 2012
Last Updated: May 7, 2013
Health Authority: United Kingdom: Research Ethics Committee

ClinicalTrials.gov processed this record on May 21, 2013